CVRx revenue rises 20 percent in first quarter as U.S. operations expand

CVRx revenue rises 20 percent in first quarter as U.S. operations expand
CVRx revenue rises 20 percent

CVRx reported a 20 percent increase in total revenue for the first quarter, signaling robust growth compared to the same period last year.

The company also recorded a 22 percent surge in U.S. revenue and announced an expansion in active U.S. implanting centers. CVRx outlined its business outlook for 2026, underscoring its commitment to sustained revenue momentum across its markets.

CVRx has highlighted the Barostim device's impact on heart failure outcomes, with Dr. Savitri Fedson sharing a case of patient improvement in previous reporting. Methodist University Hospital recently completed its first Barostim implant through a collaboration with CVRx. The expansion of implanting centers continues the company's recent efforts to broaden treatment access.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.